Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kreiter

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Human Vaccines & Immunotherapeutics|July 24, 2013
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, GermanyMustafa Diken, Sebastian Attig, Christian Grunwitz, et al.
Cancer Research|August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma ModelsNadja Salomon, Alexander Helm, Abderaouf Selmi, et al.
Human Gene Therapy|September 8, 2017
Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion ProteinsTim Beissert, Lars Koste, Mario Perkovic, et al.
Cancer Research|January 13, 2011
Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastasesThorsten Klamp, Jens Schumacher, Georg Huber, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2021
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16<sup>+</sup> cancerNadja Salomon, Abderaouf Selmi, Christian Grunwitz, et al.
Annals of Hematology|February 24, 2005
Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortalityUdo F Hartwig, Nils Winkelmann, Thomas Wehler, et al.
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Scientific Reports|April 23, 2014
Mutated tumor alleles are expressed according to their DNA frequencyJohn C Castle, Martin Loewer, Sebastian Boegel, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|July 24, 2013
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, GermanyMustafa Diken, Sebastian Attig, Christian Grunwitz, et al.
Cancer Research|August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma ModelsNadja Salomon, Alexander Helm, Abderaouf Selmi, et al.
Human Gene Therapy|September 8, 2017
Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion ProteinsTim Beissert, Lars Koste, Mario Perkovic, et al.
Cancer Research|January 13, 2011
Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastasesThorsten Klamp, Jens Schumacher, Georg Huber, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2021
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16<sup>+</sup> cancerNadja Salomon, Abderaouf Selmi, Christian Grunwitz, et al.
Annals of Hematology|February 24, 2005
Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortalityUdo F Hartwig, Nils Winkelmann, Thomas Wehler, et al.
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Scientific Reports|April 23, 2014
Mutated tumor alleles are expressed according to their DNA frequencyJohn C Castle, Martin Loewer, Sebastian Boegel, et al.
Pageof 6